{
    "2018-10-02": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Dr. Reddy's Sells Antibiotic Production Hub to UAE Drugmaker",
                "features": {
                    "keywords": [
                        "Dr. Reddy's",
                        "Antibiotic",
                        "Production Hub",
                        "UAE Drugmaker"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-07-22",
                "original_text": "Here's Why Alynlam Pharmaceuticals is Hogging the Limelight",
                "features": {
                    "keywords": [
                        "Alynlam Pharmaceuticals",
                        "Limelight"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-10",
                "original_text": "Mylan’s Biosimilar of Neulasta Expected to Be a Key Growth Driver",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Biosimilar",
                        "Neulasta",
                        "Growth Driver"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "How GlaxoSmithKline’s Vaccines Business Has Performed Recently",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "Vaccines",
                        "Performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "vaccines"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}